Bausch Health Companies (BHC) Total Debt Growth (1y) (2010 - 2026)
Bausch Health Companies (BHC) Total Debt Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -0.14% |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 37.52% |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -92.65% |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -9.19% |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 0.63% |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | - |
| 10 | Bausch Health Companies | 1.91 Bn | 1.58 Bn | 2.48 Bn | -3.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.47% |
| Dec 31, 2025 | -3.70% |
| Sep 30, 2025 | -2.16% |
| Jun 30, 2025 | 0.36% |
| Mar 31, 2025 | -2.56% |
| Dec 31, 2024 | -3.45% |
| Sep 30, 2024 | -4.12% |
| Jun 30, 2024 | 5.39% |
| Mar 31, 2024 | 6.88% |
| Dec 31, 2023 | 7.81% |
| Sep 30, 2023 | 5.73% |
| Jun 30, 2023 | -5.79% |
| Mar 31, 2023 | -10.86% |
| Dec 31, 2022 | -8.33% |
| Sep 30, 2022 | -5.11% |
| Jun 30, 2022 | -6.93% |
| Mar 31, 2022 | -2.40% |
| Dec 31, 2021 | -5.31% |
| Sep 30, 2021 | -8.15% |
| Jun 30, 2021 | -3.77% |